Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancerimplications for use in pregnancy

American Journal of Surgery

Volumn 201, Issue 1, 2011, Pages 70-75

  Pruthi, Sandhya ^a   Haakenson, Caroline ^a   Brost, Brian C ^a   Bryant, Kanesha ^a   Reid, Joel M ^a   Singh, Ravinder ^a   Netzel, Brian ^a   Boughey, Judy C ^a   Degnim, Amy C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Methylene blue; Pharmacokinetics; Sentinel lymph node biopsy

Indexed keywords

METHYLENE BLUE;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG URINE LEVEL; FEMALE; FETUS RISK; HUMAN; LYMPH VESSEL; PREGNANCY; PRIORITY JOURNAL;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COLORING AGENTS; FEMALE; HUMANS; METHYLENE BLUE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRENATAL EXPOSURE DELAYED EFFECTS; PRENATAL INJURIES; SENTINEL LYMPH NODE BIOPSY;

EID: 78650347183     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.03.013     Document Type: Article

References (32)

1. J.C. Woo, T. Yu, and T.C. Hurd Breast cancer in pregnancy: a literature review Arch Surg 138 2003 91 98
2. O. Gentilini, M. Masullo, and N. Rotmensz Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options Eur J Surg Oncol 31 2005 232 236
3. A. Keleher, R. Wendt III, and E. Delpassand The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid Breast J 10 2004 492 495
4. H.S. Cody III, J. Fey, and T. Akhurst Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures Ann Surg Oncol 8 2001 13 19 (Pubitemid 32126820)
5. A.M. Derossis, J. Fey, and H. Yeung A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer J Am Coll Surg 193 2001 473 478
6. A. Goyal, R.G. Newcombe, and R.E. Mansel Relative value of blue dye and isotope in sentinel node localization for breast cancer in a multicentre trial [abstract] Eur J Cancer 2 2004 78 79
7. R. Simmons, S. Thevarajah, and M.B. Brennan Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization Ann Surg Oncol 10 2003 242 247
8. W.D. Blessing, A.J. Stolier, and S.C. Teng A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping Am J Surg 184 2002 341 345
9. Methylene blue (systemic). In: Micromedex? Healthcare Series [intranet database]. Version 5.1. Greenwood Village, CO: Thomson Healthcare.
10. S. Zakaria, T.L. Hoskin, and A.C. Degnim Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer Am J Surg 196 2008 228 233
11. H. Schirmer, B. Coulibaly, and A. Stich Methylene blue as an antimalarial agentpast and future Redox Rep 8 2003 272 276
12. M.M. Brooks Methylene blue as an antidode for cyanide and carbon monoxide poisoning Scientific Monthly 43 1936 585 586
13. N.E. Camp Methemoglobinemia J Emerg Nurs 33 2007 172 174
14. J.D. Cragan Teratogen update: methylene blue Teratology 60 1999 42 48
15. R. Porat, S. Gilbert, and D. Magilner Methylene blue-induced phototoxicity: an unrecognized complication Pediatrics 97 1996 717 721
16. I.R. Kirsch, and H.J. Cohen Heinz body hemolytic anemia from the use of methylene blue in neonates J Pediatr 96 1980 276 278
17. J. Crooks Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue Arch Dis Child 57 1982 872 873
18. J.K. McEnerney, and L.N. McEnerney Unfavorable neonatal outcome after intraamniotic injection of methylene blue Obstet Gynecol 61 1983 35S 37S
19. R.C. Spahr, D.J. Salsburey, A. Krissberg, and W. Prin Intraamniotic injection of methylene blue leading to methemoglobinemia in one of twins Int J Gynaecol Obstet 17 1980 477 478
20. C. Peter, D. Hongwan, A. Kpfer, and B.H. Lauterburg Pharmacokinetics and organ distribution of intravenous and oral methylene blue Eur J Clin Pharmacol 56 2000 247 250
21. J. Rengelshausen, J. Burhenne, and M. Frhlich Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria Eur J Clin Pharmacol 60 2004 709 715
22. M. Gibaldi, and D. Perrier Noncompartmental analysis based on statistical moment theory J. Swarbrick, Pharmacokinetics 1982 Marcel Dekker New York 409 417
23. R.A. Corley, T.J. Mast, and E.W. Carney Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessments Crit Rev Toxicol 33 2003 137 211
24. S.Y. Khera, J.V. Kiluk, and D.M. Hasson Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping Breast J 14 2008 250 254
25. O. Gentilini, and M.Trifir Cremonesi Safety of sentinel node biopsy in pregnant patients with breast cancer Ann Oncol 15 2004 1348 1351
26. A.R. DiSanto, and J.G. Wagner Pharmacokinetics of highly ionized drugs II. Methylene blueabsorption, metabolism, and excretion in man and dog after oral administration J Pharm Sci 61 1972 1086 1090
27. E.M. Link, D.C. Costa, and D. Lui Targeting disseminated melanoma with radiolabelled methylene blue: comparative bio-distribution studies in man and animals Acta Oncol 35 1996 331 341
28. R.H. Luecke, W.D. Wosilait, B.A. Pearce, and J.F. Young A physiologically based pharmacokinetic computer model for human pregnancy Teratology 49 1994 90 103
29. J.F. Young, W.S. Branham, and D.M. Sheehan Physiological "constants" for PBPK models for pregnancy J Toxicol Environ Health 52 1997 385 401
30. I.M. Bernstein, W. Ziegler, and G.J. Badger Plasma volume expansion in early pregnancy Obstet Gynecol 97 2001 669 672
31. J.M. Davison, and M.D. Lindheimer Volume homeostasis and osmoregulation in human pregnancy Baillieres Clin Endocrinol Metab 3 1989 451 472
32. K.P. Conrad Mechanisms of renal vasodilation and hyperfiltration during pregnancy J Soc Gynecol Investig 11 2004 438 448